Home/Polaris Pharma/Chris Huxsoll, Ph.D.
CH

Chris Huxsoll, Ph.D.

Senior Vice President, Operations

Polaris Pharma

Therapeutic Areas

Polaris Pharma Pipeline

DrugIndicationPhase
ADI-PEG 20 (pegargiminase)Malignant Pleural Mesothelioma (Non-epithelioid)Phase 3 / BLA